ASSEMBLY BIOSCIENCES, INC. (ASMB) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-31

Key Insights

The CEO and President, Jason A. Okazaki, acquired 94,250 shares of common stock in the form of restricted stock units (RSUs) which vest over 4 years, indicating his confidence in the company's long-term prospects.
The RSUs granted represent 65% of Okazaki's annual equity grant, with the remaining 35% contingent on stockholder approval of an amendment to increase the shares authorized under the company's equity incentive plan.
Okazaki now beneficially owns 111,916 shares of the company's common stock, further aligning his interests with those of other shareholders.

Want the newest filings?

This analysis covers the filing from 2026-03-31. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Insider Trading filings

Filed: 2026-03-31

The reporting person, William E. Delaney IV, was granted 26,000 restricted stock units (RSUs) as part of his compensation as the Chief Scientific Officer of Assembly Biosciences, Inc. (ASMB).
The RSUs vest over four years in equal installments, indicating a long-term alignment between the reporting person and the company's performance.
A portion of the RSUs (35%) is contingent on stockholder approval of an amendment to the company's stock incentive plan, which could impact the total number of shares available for issuance.

Filed: 2026-03-31

Anuj Gaggar, the Chief Medical Officer, acquired 26,000 shares of ASMB common stock through a restricted stock unit (RSU) grant, indicating his positive outlook on the company's future.
The RSUs vest over a 4-year period, suggesting a long-term commitment from the executive to ASMB.
35% of the RSU grant is contingent on stockholder approval to increase the shares authorized under the company's equity incentive plan, aligning the executive's interests with those of shareholders.

Filed: 2026-03-31

The reporting person, Nicole S. White, acquired 26,000 shares of common stock in the form of restricted stock units (RSUs) on March 29, 2026. This indicates the company is granting equity compensation to retain its Chief Manufacturing Officer.
On March 30, 2026, the reporting person sold 197 shares of common stock to cover tax withholding obligations related to the vesting and settlement of the RSUs. This suggests the reporting person is not selling shares for personal reasons.
The reporting person currently holds 37,477 shares of common stock, indicating they maintain a substantial ownership stake in the company.

Filed: 2026-03-31

The reporting person, Jeanette M. Bjorkquist, received a grant of 6,500 restricted stock units (RSUs) that vest over 4 years, representing 65% of their annual equity award.
The reporting person sold 312 and 16 shares of common stock on March 30, 2026 to cover tax withholding obligations related to the vesting of RSUs, a mandatory 'sell-to-cover' transaction.
The reporting person's beneficial ownership of the company's common stock decreased from 11,417 shares to 11,089 shares as a result of the sell-to-cover transactions.

Other reports for ASSEMBLY BIOSCIENCES, INC.

Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.